In a new study, researchers revealed disrupted levels of molecular compounds in maternal blood and cord blood are linked to later diagnosis of autism spectrum disorder (ASD). Identification of these compounds sheds light on the biological processes that give rise to ASD and could open the door to early diagnosis and treatment. The study was led by researchers at Columbia University Mailman School of Public Health and the Norwegian Institute of Public Health. Findings appear in the journal Molecular Psychiatry.
This article was originally published on MedicalXpress.com
